TaperCommunitymodafinil
Modafinil is a wakefulness-promoting agent (eugeroic) approved for narcolepsy, obstructive sleep apnea, and shift work sleep disorder. It is widely prescribed off-label for fatigue, ADHD, and cognitive enhancement.
100mg, 200mg
Tablets: 100mg, 200mg
Avoid in pregnancy — recent data suggest increased risk of congenital malformations
Mechanism is not fully understood. Modafinil weakly inhibits the dopamine transporter (DAT), increasing extracellular dopamine. It also affects orexin/hypocretin, histamine, norepinephrine, serotonin, and GABA systems involved in wakefulness regulation.
Modafinil has low classical dependence potential, but psychological reliance and rebound fatigue/sleepiness on discontinuation are common. A 2-4 week stepdown helps with rebound symptoms.
Modafinil is not classically habit-forming, but stopping abruptly often unmasks the underlying sleep disorder. Stepwise reductions over 2-4 weeks (e.g., 200 → 100 → 50mg) plus addressing the underlying condition (CPAP for OSA, sleep schedule for shift work) reduce rebound severity.
Evidence-based phased reduction schedule. Always taper under medical supervision.
| Phase | Duration | Notes |
|---|---|---|
| Initial reduction | 1-2 weeks | Reduce from 200mg to 100mg daily. Most users tolerate this step well. |
| Middle reduction | 1-2 weeks | Reduce to 50mg (half-tablet) or alternate-day dosing. |
| Final discontinuation | 1-2 weeks | Discontinue. Consider lifestyle/sleep-hygiene support and address underlying conditions. |
1-2 days after dose reduction
3-7 days
Typically within 1-2 weeks for most symptoms
Rebound fatigue and low mood may persist 2-4 weeks; underlying sleep disorders re-emerge if unaddressed
Practical insights shared by members tapering Provigil. Not medical advice — always consult your prescriber.
Toxicity
Severe rash including Stevens-Johnson syndrome (rare). Cardiovascular effects (tachycardia, hypertension). Psychiatric effects including mania, psychosis, and suicidal ideation.
Pharmacokinetics
Rapidly absorbed, Tmax 2–4 hours. Food may delay absorption but does not affect overall bioavailability.
~0.9 L/kg
Hepatic metabolism, primarily via amide hydrolysis and CYP3A4 to inactive metabolites (modafinil acid, modafinil sulfone).
Renal (~80% as metabolites), <10% unchanged.
~60% (primarily albumin)
~50 mL/min
Browse our map of deprescribing-informed providers worldwide.